Detalhe da pesquisa
1.
Efficacy and safety of crisaborole ointment, 2%, in participants aged ≥45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase 2a study.
J Am Acad Dermatol
; 90(5): 945-952, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340127
2.
Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis.
Dermatology
; 240(2): 243-253, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38081155
3.
Predictors of nonresponse to dupilumab in patients with atopic dermatitis: A machine learning analysis.
Ann Allergy Asthma Immunol
; 129(3): 354-359.e5, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35640774
4.
Improvement in disease severity and pruritus outcomes with crisaborole ointment, 2%, by baseline atopic dermatitis severity in children and adolescents with mild-to-moderate atopic dermatitis.
Pediatr Dermatol
; 37(6): 1030-1037, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32981097
5.
Real-world evidence on atopic dermatitis: Baseline characteristics and predictors of treatment choice in the TARGET cohort.
J Am Acad Dermatol
; 89(2): 345-347, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36521798
6.
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2.
Am J Clin Dermatol
; 25(1): 127-138, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37624488
7.
A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia.
BMC Infect Dis
; 13: 268, 2013 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23742753
8.
Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis.
Dermatol Ther (Heidelb)
; 13(4): 951-960, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36811773
9.
Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study.
Am J Clin Dermatol
; 24(4): 623-635, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37184828
10.
The Measurement Performance of the Parkinson's Disease Activities of Daily Living, Interference, and Dependence Instrument.
Front Neurol
; 13: 760174, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35432147
11.
Memory-Assisted Global Impression of Change (MAGIC).
Ther Innov Regul Sci
; 56(3): 454-463, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35192169
12.
The economic burden of Parkinson disease among Medicare beneficiaries.
J Manag Care Spec Pharm
; 28(4): 405-414, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35332791
13.
Patient and caregiver preferences on treatment attributes for atopic dermatitis.
J Dermatolog Treat
; 33(4): 2225-2233, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34264145
14.
Real-World Effectiveness of Newly Initiated Systemic Therapy for Atopic Dermatitis in the United States: A Claims Database Analysis.
Adv Ther
; 39(9): 4157-4168, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35821555
15.
Health Care Resource Utilization Associated With Parkinson Disease Among Medicare Beneficiaries.
Neurology
; 97(6): e597-e607, 2021 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34045274
16.
Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes.
Am J Clin Dermatol
; 22(4): 541-554, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33954933
17.
Relationship Among Treatment, Pruritus, Investigator's Static Global Assessment, and Quality of Life in Patients with Atopic Dermatitis.
Dermatol Ther (Heidelb)
; 11(2): 587-598, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33751495
18.
A microsimulation of the cost-effectiveness of maraviroc for antiretroviral treatment-experienced HIV-infected individuals.
HIV Clin Trials
; 11(2): 80-99, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20542845
19.
The Parkinson's Disease Activities of Daily Living, Interference, and Dependence Instrument.
Mov Disord Clin Pract
; 6(8): 678-686, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31745478
20.
Correction to: Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes.
Am J Clin Dermatol
; 22(5): 739, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34406620